x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Wegovy

Inception Point Ai

This series on Wegovy provides an in-depth look into the popular weight loss medication. The first episode introduces Wegovy, explaining its mechanism, clinical trials, and patient eligibility. The second episode delves into the benefits and potential risks, including effectiveness, side effects, and comparisons with other treatments. The final episode covers practical considerations such as usage, lifestyle integration, cost, and future developments. This series offers a comprehensive understanding

health & fitness medicine

All Episodes

6:31

Wegovy Weight Loss Drug Battles Compounders, Expands...

Wegovy ·

2025/08/12

# The Wegovy Revolution: Access, Competition, and Navigating Weight Management MedicineIn this compelling episode of our podcast, we delve into the rapidly evolving landscape of weight management medicine, focusing on Novo Nordisk's groundbreaking drug Wegovy. Host Alexandra Reeves guides listeners through recent developments that impact healthcare access, market dynamics, and patient decisions.Discover how Wegovy secured preferred status on CVS Health Caremark's national formulary, potentially

en

6:24

Wegovy Dominates Weight Loss Market: Novo Nordisk...

Wegovy ·

2025/08/09

# Inside the Wegovy Revolution: How Novo Nordisk's Weight Loss Drug Is Reshaping HealthcareDive into the latest developments surrounding Wegovy, the groundbreaking weight loss medication that's become a cultural phenomenon beyond the pharmaceutical world. This episode explores Novo Nordisk's recent insurance victory with CVS Health Caremark, impressive financial growth despite challenges from knockoff drugs, and the ongoing legal battle against compounded versions of semaglutide.We examine the FDA's

en

6:24

Wegovy Weight Loss Drug Faces Market Challenges Amid...

Wegovy ·

2025/08/05

# Wegovy's Weight Loss Revolution: Market Tumult, Legal Battles, and New ContendersExplore the rapidly evolving landscape of weight-loss medications as host Alexandra Reeves dives deep into Wegovy's dramatic journey. This episode unpacks Novo Nordisk's recent 20% stock plunge amid rising competition from compounded semaglutide alternatives, despite the official end to medication shortages. Learn about the concerning wave of lawsuits alleging undisclosed side effects, including a 250% increase in

en

6:33

Wegovy Weight Loss Drug: Breakthrough Medication...

Wegovy ·

2025/08/02

# Wegovy in Focus: The Weight Loss Revolution Transforming HealthcareDive into the latest episode of Alexandra Reeves' investigative podcast exploring Wegovy, the groundbreaking weight loss medication reshaping healthcare and society. With over 30 years of global reporting experience, Reeves examines the profound impact of this GLP-1 medication that helps patients lose an average of 15% body weight—far surpassing traditional methods.This episode unpacks recent developments including:- CVS Caremark's

en

6:12

Wegovy Weight Loss Drug Faces Legal Challenges,...

Wegovy ·

2025/07/29

# Weight Loss Revolution: Wegovy's Market Impact, Legal Battles, and Health ImplicationsDiscover the latest developments in the world of weight management as host Alexandra Reeves explores Wegovy's evolving story. This episode dives into Novo Nordisk's recent financial challenges, the growing controversy over counterfeit GLP-1 medications, and the legal battles reshaping the weight loss drug landscape.Learn how pharmacy benefit managers like CVS Caremark are changing patient access, why lawmakers

en

6:11

Wegovy: Revolutionizing Weight Loss and Addiction...

Wegovy ·

2025/07/26

# The Wegovy Revolution: Transforming Obesity Treatment Amid Counterfeits, Rebounds, and New Medical FrontiersDive into the groundbreaking world of Wegovy, the weight-loss medication reshaping obesity treatment. Alexandra Reeves explores the dramatic impact of semaglutide injections, which help patients lose up to 15% of body weight in clinical trials. Learn about the dangerous counterfeit market emerging as demand outpaces supply, with 80+ lawmakers urging FDA action against potentially harmful

en

5:51

Wegovy Weight Loss Drug Sparks Global Controversy:...

Wegovy ·

2025/07/22

# Wegovy: Miracle Weight Loss Drug or Problematic Solution? - Health News PodcastJoin Alexandra Reeves in this eye-opening episode exploring Wegovy's extraordinary rise in popularity and its wide-ranging impacts. Discover how this injectable semaglutide medication has transformed obesity treatment while creating significant challenges - from nationwide shortages affecting 25,000 new weekly patients to alarming legal battles over serious side effects including blood clots, vision loss, and digestive

en

6:28

Wegovy: The Weight Loss Drug Transforming Healthcare,...

Wegovy ·

2025/07/19

# Wegovy's Impact: Blockbuster Weight-Loss Drug Faces Access Challenges Despite Soaring DemandIn this insightful episode of Global Dispatch, host Alexandra Reeves examines the meteoric rise of Wegovy, the groundbreaking weight-loss medication that has transformed both the pharmaceutical industry and public health conversations. Discover how this GLP-1 drug generated nearly $1.9 billion in US sales alone last quarter—an 83% year-over-year increase—while still remaining inaccessible to millions of

en

6:14

Wegovy Breakthrough: New 7.2 mg Dose Promises...

Wegovy ·

2025/07/15

# Wegovy's Evolution: Higher Doses, Greater Weight Loss, and the Changing Landscape of Obesity TreatmentDiscover the latest breakthroughs in obesity management as host Alexandra Reeves explores Novo Nordisk's application for a stronger 7.2mg Wegovy dose. Learn how clinical trials show unprecedented weight loss results—up to 21% of total body weight—rivaling bariatric surgery outcomes. This episode dives into the science behind GLP-1 medications, practical lifestyle strategies for patients,

en

6:07

Wegovy Breakthrough: Novo Nordisk Unveils Higher Dose...

Wegovy ·

2025/07/12

# Breaking News: Wegovy's Game-Changing 7.2mg Dose & The Future of Obesity TreatmentJoin host Alexandra Reeves as she unpacks the latest breakthrough in weight loss medication: Novo Nordisk's submission of a powerful new 7.2mg Wegovy dose to European regulators. This episode explores the STEP UP clinical trials showing remarkable 21% average weight loss results, with one-third of participants losing a quarter of their body weight.Discover how this pharmaceutical innovation impacts obesity treatment

en

6:44

Wegovy Revolution: Breakthrough Weight Loss Drug...

Wegovy ·

2025/07/08

# The Wegovy Revolution: From Lab Promise to Global Health Game-ChangerDiscover the extraordinary journey of Wegovy, the weight-loss medication transforming millions of lives worldwide. In this eye-opening episode, Alexandra Reeves explores how semaglutide evolved from scientific footnote to household name, examining Novo Nordisk's bold move to introduce a high-dose 7.2mg version to European regulators that could generate billions in additional revenue.Learn how this groundbreaking medication helps

en

6:39

Wegovy Revolutionizes Weight Loss: Breakthrough...

Wegovy ·

2025/07/05

# The Wegovy Revolution: How This Weight Loss Treatment is Reshaping Health in 2025Explore the groundbreaking impact of Wegovy (semaglutide) on global healthcare and obesity treatment in this insightful podcast episode with Alexandra Reeves. Discover how this former diabetes medication transformed into a weight loss phenomenon that's making headlines from London to Singapore.This episode dives deep into Wegovy's remarkable journey - from its clinical success with millions of NHS prescriptions to

en

6:01

Wegovy Shakes Up Weight Loss Market: Novo Nordisk...

Wegovy ·

2025/06/23

# Breaking News: Wegovy & Obesity Treatment Shake-up | Quiet Please PodcastJoin veteran global reporter Alexandra Reeves as she unpacks the latest dramatic developments in the world of obesity treatment. In this must-listen episode, discover why pharmaceutical giant Novo Nordisk abruptly ended its partnership with telehealth provider Hims and Hers over allegations of counterfeit Wegovy products. Learn about groundbreaking clinical research unveiled at the American Diabetes Association summit,

en

6:15

Wegovy: The Revolutionary Weight Loss Drug...

Wegovy ·

2025/06/21

# The Wegovy Revolution: How a Single Drug is Reshaping Healthcare, Economics, and SocietyJoin host Alexandra Reeves as she explores the unprecedented impact of Wegovy beyond weight loss. This eye-opening episode reveals how Novo Nordisk's blockbuster medication is transforming multiple industries worldwide—from a patent protection lapse in Canada to its groundbreaking FDA approval for cardiovascular protection. Discover the latest developments in oral formulations, supply chain challenges, and

en

5:40

Wegovy Revolutionizes Weight Loss: FDA Approves...

Wegovy ·

2025/06/16

# Wegovy: Transforming Weight Loss & Heart Health - with Alexandra ReevesJoin veteran international correspondent Alexandra Reeves as she explores Wegovy, the groundbreaking medication revolutionizing obesity treatment and cardiovascular health. This episode dives into Wegovy's dual impact: significant weight loss benefits and its FDA approval for reducing serious heart problems in adults with cardiovascular disease and obesity.Discover how increased accessibility is changing lives as the FDA

en

6:00

Wegovy: Breakthrough Obesity Drug Sparks Hope and...

Wegovy ·

2025/06/14

# Wegovy Breakthrough: The Future of Obesity Treatment ExploredDiscover the latest developments in obesity care as veteran journalist Alexandra Reeves examines Wegovy's impact on healthcare worldwide. This insightful episode delves into recent pricing announcements, emerging legal challenges, and breakthrough research that's reshaping weight management treatment.Listen as Reeves unpacks critical updates including Novo Nordisk's temporary $499 pricing strategy, the growing number of lawsuits

en

6:03

Wegovy Weight Loss Drug Sparks Controversy: Eye...

Wegovy ·

2025/06/09

# Wegovy: The Science, Business, and Human Experience Behind a Transformative Weight Loss DrugJoin host Alexandra Reeves as she takes you beyond the headlines to explore the multifaceted world of Wegovy, one of the decade's most significant weight loss medications. This comprehensive episode examines recent developments including rare eye condition warnings from European regulators, the dramatic rise in teenage prescriptions, temporary price reductions, and the potential game-changing FDA

en

3:47

Wegovy Breaking News: Safety Updates, Price Cuts, and...

Wegovy ·

2025/06/07

# The Latest on Wegovy: Breaking Developments in Weight Loss Medication - Podcast Episode DescriptionDive into the latest breaking news surrounding Wegovy, the groundbreaking weight loss medication that's transforming the healthcare landscape in 2025. In this informative episode, host Alexandra Reeves delivers comprehensive coverage of crucial developments affecting millions of potential and current users.Discover the European Medicines Agency's recent safety findings about a rare eye condition

en

5:30

Novo Nordisk Slashes Wegovy Price Amid FDA...

Wegovy ·

2025/06/02

# Breaking News: Novo Nordisk Slashes Wegovy Prices as FDA Ends CompoundingIn this timely episode, we explore Novo Nordisk's strategic move to temporarily reduce Wegovy pricing to $199 for the first month and $499 thereafter for new self-paying patients. This price cut coincides with the FDA ending its grace period for compounded GLP-1 medications, potentially reshaping access to weight loss treatments. We discuss the implications for patients seeking affordable options, with remarkable success

en

6:23

Wegovy Weight Loss Drug Faces Compounding Ban and...

Wegovy ·

2025/05/31

# Wegovy's Global Impact: Inside the Weight Loss RevolutionExplore the complex world of Novo Nordisk's groundbreaking weight loss drug Wegovy with veteran global health journalist Alexandra Reeves. This eye-opening episode delves into the recent federal ban on compounded semaglutide, Novo Nordisk's response with discounted patient offers, and the intensifying competition from Eli Lilly's Zepbound. Learn about the promising oral semaglutide pill awaiting FDA approval, leadership changes in Europe,

en

78 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown